By Tom Hall, Sam Bermas-Dawes, Rob Sivak
WYPR
Published September 2, 2025
EXCERPT: Last month, the Maryland Drug Affordability Board decided to label a pair of Type 2 diabetes medications unaffordable for state and local governments…So, what comes next? When can consumer expect to see the board’s efforts translate into lower costs?
Andrew York, the Executive Director of the Maryland Prescription Drug Affordability Board, joined Midday to discuss the latest.
Listen to the full discussion at WYPR.
Last modified: September 9, 2025
